Xylazine and Overdoses
Trends, Concerns, and Recommendations
Bibliographic Data
Xylazine is a nonopioid veterinary anesthetic and sedative that is increasingly detected in the illicit drug supply in the United States. Data indicate a striking prevalence of xylazine among opioid-involved overdose deaths. The emergence of xylazine in the illicit drug supply poses many unknowns and potential risks for people who use drugs. The public health system needs to respond by increasing testing to determine the prevalence of xylazine, identifying its potential toxicity at various exposure levels, and taking mitigating action to prevent harms. Currently, there is little testing capable of identifying xylazine in drug supplies, which limits the possibility of public health intervention, implementation of harm reduction strategies, or development of novel treatment strategies. (Am J Public Health. 2022;112(8):1212–1216. https://doi.org/10.2105/AJPH.2022.306881 )
Political science · Employment, Labor, and Gender Studies · Social Policy and Reform Studies · Social Sciences and Policies
Navigating US illicit drug market volatility
Motivational interviewing to increase drug checking and reduce overdose rates among people who use drugs
Xylazine’s Impacts on the Community in Philadelphia
“All You Can Do is What You Know to Do”
“Everybody’s Liking It”—Intentional Use of Xylazine in Fentanyl Among People Who Use Drugs
Point‐Of‐Care Drug‐Checking
Makeshift medicine is a response to US health system failures
Exploring trauma and wellbeing of people who use drugs after witnessing overdose
Media framing xylazine as a “zombie drug” is amplifying stigma onto people who use drugs
Emergence of xylazine in accidental overdose deaths, impaired drivers, sexual assaults, and public intoxications within San Francisco
Perspectives on prescribed safer supply programs among people who inject drugs in Baltimore, Maryland
Volatile drug use and overdose during the first year of the Covid-19 pandemic in the United States
A place-based spatial analysis of racial inequities in overdose in St. Louis County Missouri, United States
Wound-associated agents in the unregulated drug supply
| Citations per year | 4.67 |
|---|---|
| Citation span | 2023 - 2026 (4) |
| Highly cited | No |